MicroRNAs were discovered more than 2 decades ago and have profound impact on diverse biological processes. Specific microRNAs have important roles in modulating the innate immune response and their dysregulation has been demonstrated to contribute to inflammatory diseases.
INTRODUCTION
MicroRNAs (miRNAs) are small, single-stranded RNAs that range from 20-25 nucleotides in length. MiRNAs function through binding of target mRNA and thereby alter gene expression via posttranscriptional regulation. miRNAs are involved in almost all aspects of biological processes involving development, cellular differentiation, immune modulation, and pathogenic conditions. miRNAs alter mRNA function via blockade of translation or RNA degradation and it is predicted that approximately 60% of human genes are controlled by miRNAs. [1] [2] [3] [4] [5] [6] [7] The specificity of mRNA targeting relies on a sequence of the miRNA, termed the 'seed' sequence, that binds complementary to the 3 ′ untranslated region (3 ′ UTR) of the mRNA. 8 Thus one miRNA is capable Abbreviations: 3 ′ UTR, 3 ′ untranslated region; ALI, acute lung injury; ARDS, acute respiratory distress syndrome; BALF, bronchial alveolar lavage fluid; BM, bone marrow; DAMP, damage-associated molecular patterns; DC, dendritic cell; DGCR8, DiGeorge syndrome chromosomal region 8; DSS, dextran sodium sulfate; IBD, inflammatory bowel disease;
MiRNA, microRNA; PaO2/FiO2, arterial oxygen partial pressure to fractional inspired oxygen ratio; PMNs, polymorphonuclear neutrophils; Pre-miRNA, Precursor miRNA; RISC, RNA-induced silencing complex; RNAi, RNA interference; VILI, ventilation induced lung injury of targeting multiple mRNAs and the function of the targeting mRNAs are usually cell and tissue specific. Being a crucial functional element of gene regulation, miRNAs have significant degree of homology between different species. miRNAs have been shown to be proficient modulators of immune responses being involved in myeloid cell differentiation and function, in adaptive immune response by modulating B and T cells development, and in the crosstalk between immune and resident cells. 9, 10 Recent reports have identified several miRNAs to be important regulators of immune responses. For instance, expression of miR-146a increases after LPS exposure in human THP-1 cells (human monocytic cells) in an NF-B dependent manner. 11 The same study identified IL-1 receptor associated kinase (IRAK1) and TNF receptor associated factor 6 (TRAF6) as pro-inflammatory targets of miR146a during TLR activation. 11 Murine models of LPS instillation results in massive inflammation led by neutrophil and macrophage activation and also resulted in altered expression of miRNAs, including miR146a, miR-155, miR-21, and miR-223. 12, 13 MiR-223, in particular, has been shown to be essential for innate immune responses governing myeloid differentiation and granulocyte functions. 14, 15 Recent studies . Pri-miRNAs are cleaved by Drosha complexed with DiGeorge syndrome critical region 8 protein (DGCR 8) to release precursor miRNAs (pre-miRNA). Then pre-miRNAs are transported to the cytosol and further processed by Dicer to reveal a double-stranded miRNA duplex. The mature strand of the miRNA duplex associates with the RNA silencing complex (RISC) to repress target mRNAs via binding to the 3 ′ untranslated region (3 ′ UTR) region. MiRNAs achieve targeted gene repression via two major mechanisms: inhibition of mRNA translation and degradation of target mRNA. Additionally, recent studies suggest that miRNAs can also bind to 5 ′ UTR region and promoter region of the mRNA target to achieve translation activation. In conclusion, the biogenesis of miRNAs is tightly regulated by specific cellular location and RNase to generate mature RNA. The main function of miRNAs is to modulate protein levels via diverse mechanisms. Adapted from Neudecker et al. MicroRNAs in mucosal inflammation. 2 demonstrated abnormal expression of miR-223 in various pathogenic conditions, such as type II diabetes, acute lung injury (ALI), rheumatoid arthritis, and inflammatory bowel disease (IBD). [16] [17] [18] [19] This review discusses the established role of miR-223 in myeloid development of differentiation and highlights the recently acquired insights into the function of miR-223 during innate immunity. We also highlight therapeutic options targeting miR-223 for the treatment of mucosal inflammation such as those occurring during IBD or ALI. These studies indicate that overexpression of miR-223 via nanotechnology-based delivery can be used to treat or prevent uncontrolled inflammation of the lungs or the intestine. 2, 18, 19 2 miRNA BIOSYNTHESIS AND FUNCTION
History of discovery
The first miRNA-mRNA interference was discovered in 1993 in Caenorhabditis elegans with a miRNA named lin-4. 20, 21 Lin-4 was first identified as a heterochronic gene that functions to control the development of C. elegans. However, there is no conventional start and stop codons in lin-4 gene, which led to the conclusion that lin-4 did not translate into/code for protein. 20 In 1993, Ambros and Ruvkun have independently reported the interaction between lin-4 and the 3 ′ UTR of its target gene lin-14. 20, 21 After 7 years of silence in miRNA research, the second miRNA, let-7 was identified in C. elegans in 2000 as essential for the development of C. elegans. 22 Following studies discovered that let-7 is conserved in various species and thus sparked researcher's interest in miRNA in other organisms including the mammalian system. 23 In the meantime, the discovery of RNA interference (RNAi), a process that utilizes 21-23 nucleotide long dsRNA to inhibit gene expression posttranscriptionally, supported a potential mechanism of function for miRNA regulation of target mRNA. 24 Altogether, the discovery of functional miRNAs in C. elegans as well as the advanced understanding of RNAi triggered significant progress in the identification of miRNAs and their mechanism of action in the past decades. With the advancement of RNA sequencing and related technology, exceedingly more miRNAs have been identified. In the most recent miRBase release, there are 28,645 entries of hairpin precursor miRNAs that express 35,828 mature miRNA products, in 223 species including 2588 human mature miRNAs. 25 
Biogenesis and maturation
The biogenesis of miRNAs is unique when compared with other protein-encoding genes and tightly controlled by cellular localization and miRNA specific enzymes (Fig. 1) . Similar to mRNAs, miRNAs are initially transcribed as long primary miRNAs (pri-miRNAs) in the nucleus. 26 These long pri-miRNAs are poly-adenylated at the 3 ′ end and capped at the 5 ′ end. Pri-miRNAs are then cleaved by RNaseII endonuclease III Drosha/ DiGeorge syndrome chromosomal region 8 (DGCR8) complex resulting in a 60-110 nt precursor-miRNA (pre-miRNA). 26, 27 Pre-miRNAs are subsequently transported from the nucleus to the cytoplasm where they are cleaved by another specific RNase III Dicer-1 into double-stranded miRNA duplexes. 28 Pre-miRNA is further processed into a structure of approximately 20 nt mature miRNA. Both Drosha/DGCR8 and Dicer are crucial for miRNA biosynthesis. As a result, mice with conditional or global genetic deletion of Drosha or Dicer all show severe and lethal abnormality in their development. 29, 30 Once an miRNA is fully matured, it will associate with and guide the RNA-induced silencing complex (RISC) to the target mRNA. The binding to mRNA targets with sequences complementary to the sequence of the miRNA will function to regulate the translation and degradation of target transcripts. 31 
Function of miRNA via regulation of target genes
The main function of miRNAs is to repress target genes via inhibition of mRNA translation or degradation of target mRNA (Fig. 1) .
Degradation or destabilization of the target mRNA serves as the dominant mechanisms for the inhibition of protein production whereas translational inhibition only modestly represses protein production. 32 The most common mRNA site for miRNA binding is the 3 ′ UTR and this mechanism is one of the most accepted for target gene regulation. For instance, the majority of the target prediction databases for miRNAs suggest potential miRNA-mRNA interaction based on the sequence of 3 ′ UTR of mRNAs. However, recent studies suggested that miRNA can also target the 5 ′ UTR site of mRNA to achieve gene repression. 33, 34 Others have also identified binding sites of miRNAs in the coding region of mRNAs, indicating the complexity of mRNAmiRNA interaction. 35 Beside its classic function of gene repression, miRNAs can also serve as transcription and translation activators of target genes (Fig. 1) . One of the first reports of miRNA mediated induction of target mRNA is from Place and colleagues, which demonstrated the targeting of miR-373 to the promoter region of E-cadherin and coldshock domain-containing protein C2 (CSDC2) to induce expression. 36 Another classic example of miRNA activated gene expression is miR-122 mediated activation of hepatitis C (HepC) virus translation, which facilitates the propagation of HepC virus in hepatocytes. 37, 38 In the follow-up study, Jopling and colleagues showed that miR-122 targets the 5 ′ UTR region of the HepC RNA to facilitate translation activation. 39 Subsequent clinical studies in patients demonstrated that miR-122 can be inhibited in patients to prevent replication of the HepC virus. 40 On the other hand, miR-122 can also target the 3 ′ UTR of CCCTC-binding factor (CTCF) and mediator 1 (MED1) to repress gene expression in hepatoma cells. 41 In conclusion, miRNAs modulate target gene expression via diverse mechanisms.
miR-22IN INNATE IMMUNITY
miR-223 is located on the X chromosome governed by an independent promoter not related to other gene products. miR-223 is preferentially expressed by hematopoietic cells especially the CD34 − bone marrow (BM) cells but absent in T and B cells. 42 Mice with genetic disruption of miR-223 are viable, fertile, and born according to the Mendelian ratio with no gross abnormalities. 43 However, hemizygous miR-223 −/y mice showed profound neutrophilia in peripheral blood and 11-12 month old miR-223 −/y mice spontaneously develop lung inflammation marked by neutrophil infiltration. 43 There have been no differences between male and female miR-223 deficient mice reported so far. miR-223 −/y mice have been studied in several murine disease models to investigate the impact of miR-223 in innate immunity. In this review, we will focus on the function of miR-223 in myeloid differentiation, neutrophil function, and macrophage functions. We will also discuss the involvement of miR-223 in nonmyeloid cells, showcasing the diverse role of miR-223.
miR-223 in the regulation of myeloid differentiation
MiR-223 is most highly expressed in the myeloid compartment and, did not impede granulocytes differentiation but caused increased levels of neutrophils due to expanded myeloid progenitor cells. 43 The same study identified myocyte-specific enhancer factor 2C (Mef2c) as a target of miR-223 that promotes expansion of myeloid progenitor cells and disruption of Mef2c in miR-223 −/y mice rescued the granulopoietic phenotype. 43 Beside the process of granulopoiesis, the differentiation of monocyte to macrophage is crucial for the activation of innate immune responses and the initiation of adaptive immunity. 45 The expression level of miR-223, alongside with miR-15 and miR-16, decreased significantly during the process of macrophage differentiation induced by inflammatory stimuli, such as PMA and LPS. 46 The lowering of those 3 miRNAs increases the expression of target gene inhibitor of nuclear factor kappa-B kinase subunit alpha (IKK ) to finetune the inflammatory responses of macrophages via the alternation of noncanonical NF-B pathway. 46 As an intriguing example of miR-223 ′ s diverse involvement of granulocyte production and differentiation, a recent study by Vian and colleagues demonstrated upregulation of miR-223 during granulopoiesis and monocytopoiesis in CD34 + HPCs and further described a functional role of miR-223 during myeloid development. 47 Specifically, overexpression of miR-223 in CD34 + HPCs enhances granulopoiesis while concurrently dampening erythroid and macrophage differentiation. On the other hand, inhibition of miR-223 impairs granulopoiesis while enhancing erythroid and macrophage differentiation. In summary, miR-223 is essential and has a diverse functional role in orchestrating myeloid progenitor cell differentiation.
miR-223 in the regulation of neutrophil function
The function of miR-223 as a negative regulator of neutrophil activation and chemotaxis has been demonstrated in multiple experimental models of inflammatory diseases. Neutrophils are important for the development and modulation of mucosal inflammation. 48 An earlier study by Johnnidis et al. described the regulatory effects of miR-233 on neutrophil function. miR-223 −/y mice have more neutrophils in the BM, as well as peripheral tissue including the blood and the lungs, and those neutrophils are hyperactive with increased inflammatory phenotypes, such as respiratory burst and fungistatic activity. 43 Furthermore, miR-223 is expressed stably at high levels in neutrophils and overexpression of miR-223 was shown to diminish NLR family pyrin domain containing 3 (NLRP3) inflammasome activity via direct targeting of NLRP3 and in turn dampens NLRP3-dependent IL-1 production. 49 The NLRP3-miR-223 axis was further studied in acute lung injury (ALI). 50 Patients with acute respiratory distress syndrome (ARDS) caused by trauma and blood transfusion showed high level of miR-223 in the bronchial alveolar lavage fluid (BALF) when compared with health controls. In ALI induced by mitochondrial damage-associated molecular patterns (DAMPs) (MTDs), miR-223 −/+ mice experienced decreased arterial oxygen partial pressure to fractional inspired oxygen ratio (PaO 2 /FiO 2 ), increased lung wet to dry ratio, and elevated infiltrating cells to the airway. Ly-6G + neutrophils were identified as a key mediator of MTD induced ALI and miR-223 limits the number of Ly6G + neutrophils and inhibits the NLRP3 inflammasome activity. In the context of neuronal injury and inflammation, miR-233 is located in the neutrophils recruited to the area of spinal cord injury in mice that is associated with high levels of inflammatory cytokines. 51 Additionally, miR-223 was found to control lung recruitment of neutrophils during tuberculosis infection by direct targeting of chemoattractant CXCL2, CCL3, and IL-6 in myeloid cells. 52 Indeed, higher miR-223 levels were identified in the blood and lung tissue of tuberculosis (TB) patients and mice infected with TB. MiR-233 deletion in mice resulted in lethal neutrophil-driven inflammation during TB infection.
However, this study did not observe any differences in the bacterial killing ability of macrophages and neutrophils. The regulatory role of miR-223 in neutrophil activation and function was further explored in hepatic injury models. miR-223 acts as a negative regulator to neutrophil activation during acetaminophen (APAP) overdose. 53 APAP overdose elicits the level of miR-223 in neutrophils to limit neutrophil activation and prevent further liver injury. Elevated miR-223 level inhibits the expression of its target gene IKK and subsequently dampens TLR-NF B inflammatory pathway during APAP overdose induced liver injury. Furthermore, in alcoholic liver injury, miR-223 was shown to be increased in serum from alcoholic patients and in serum and neutrophils from mice with chronic and binge alcohol consumption. 54 Similarly to APAP overdose model, miR-223 −/y mice are more susceptible to alcohol induced liver injury with increased hepatic neutrophil infiltration, ROS production, and IL-6 expression, suggesting the regulatory role of miR-223 to control neutrophil activity during hepatic inflammation. In summary, miR-223 is highly expressed in neutrophils and plays essential role to limit the activation and function of neutrophil in inflammatory diseases. Thus miR-223-based therapy would be beneficial to limit neutrophil driven inflammation to avoid excess immune responses. and decrease the expression of IL-1 , IL-6, TNF-, and IL-12p40 genes in macrophages. 58 In TB infected patients, increased miR-223 levels in monocyte-derived macrophages correlated with impaired activation and cytokine production when compared to healthy individuals.
miR-
Mechanistically, miR-223 dampened NF-B activation in U937 cells (human monocytic cells) by negative regulation of p65 phosphorylation, which in turn resulted in reduced production of inflammatory cytokines. A recent study suggested that miR-223 targets the circadian rhythm molecule brain and muscle ARNT-like 1 (BMAL1), which was shown to alter the matrix metalloproteinase (MMP) production in macrophages in response to mycobacteria tuberculosis infection. 59 
FUNCTIONAL ROLE OF miR-223 IN NONHEMATOLOGIC CELLS
Besides the function of miR-223 in hematologic cells, increasing evidence shows the potential role of miR-223 in nonhematologic malignancies. 14, 64 For example, miR-223 is one of the most upregulated miRNAs in recurrent ovarian cancer when compared with primary ovarian cancer. 65 miR-223 is also shown to be up-regulated in gastric cancer and promotes invasion and metastasis driven by Twist, a transcription factor highly expressed in metastatic gastric cancer. 66 Overexpression of miR-223 in gastric cancer cells promotes the inva- 
FUNCTIONAL ROLES OF MYELOID miR-223 DURING INFLAMMATORY DISEASES

Shuttling of miR-223 during acute respiratory distress syndrome
Besides the cell intrinsic function of miR-223 in myeloid cells to modulate innate immunity, miR-223 is also contained in microvesicles to Shuttling of miR-223 has also been investigated beyond the scope of cancer and liver inflammation. A recent study found a novel role of miR-223 shuttling to orchestrate the pulmonary immune responses in acute respiratory distress syndrome (ARDS; Fig. 2 ). 18 ARDS is a syndrome characterized by acute respiratory failure in the setting of noncardiogenic pulmonary edema. 72 Among its hallmarks is the initiation of a very robust inflammatory response, a disruption of the alveolarcapillary barrier, pulmonary edema, and attenuated gas exchange.
ARDS contributes significantly to morbidity and mortality of critical ill patients with a mortality rate as high as 60%, 73 and long-term disability and decreased quality of life are dramatic. 74 In the search of potential 
miR-223 in inflammatory bowel diseases
IBD, including Crohn's disease and ulcerative colitis, are characterized by disrupted epithelial barrier function, increased bacterial translocation and dysregulated immunological environment in the gut. [75] [76] [77] [78] [79] [80] [81] [82] [83] Adaptive immunity, Th17 responses especially, plays a crucial role in the propagation of inflammation during IBD. 84, 85 On the other hand, dendritic cell (DC) and macrophages are also crucial in the maintenance of intestinal immune homeostasis. 86 Given the fact that miR-223 modulates the differentiation of monocytes, several stud- (Fig. 3) . 19 The expression level of miR-223 was shown to increase in intestinal biopsies as well as inflamed colon tissue of mice treated with dextran sodium sulfate (DSS). To determine the function of miR-223 in intestinal inflammation, miR-223 deficient mice were exposed to DSS in the drinking water to chemically induce colitis. Exacerbated intestinal 
CONCLUSION AND PERSPECTIVES
To summarize, several exciting research studies suggest that miR-223 serves as a crucial regulator in innate immunity, ranging from myeloid differentiation to neutrophil and macrophage functions. (Table 1 ). Based on recent translational studies, we are
anticipating that there will also be clinical trials targeting miR-223 function during inflammatory disease. In conclusion, already utilized as biomarker in several inflammatory diseases, the tissue specific role and therapeutic potential of miR-223 will likely be further investigated as we search for safe and effective treatment for inflammatory diseases.
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